Local genomic testing will cut wait times and uncertainty for cancer patients, Health Minister Simeon Brown says. The ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that the U.S. Food and Drug Administration (FDA) has approved the MyChoice ® CDx ...

Germline testing is a genetic screening that looks for inherited gene mutations found in every cell.  It can identify ...

The future of precision medicine will depend less on choosing between genomics or real-world evidence and more on how effectively the two are integrated.

Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple ...

Germline testing can identify hereditary cancer, which leads to implications for family members, cascade testing for relatives, and starting surveillance and prevention measures: Genetic testing in ...

In 2023, Jill Martin took a test that changed her life. She underwent genetic testing for breast cancer and learned she had a BRCA2 mutation, which increases one’s risk of developing breast and other ...

A study highlights a gap in cancer prevention, showing men undergo genetic testing less often yet are more likely to carry high-risk cancer variants.

We are at a transformative moment in oncology. Remarkable advancements have led to the identification of biomarkers that can predict treatment response, tests that can detect cancer risk before ...

New Zealanders with cancer and rare disorders will benefit from faster, locally delivered genomic testing through a new ...

Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...